Cancer Institute A national cancer institute
designated cancer center

May 2010 Cancer Center Bulletin

Director's Message

Dear Cancer Center members,

MANY KUDOS THIS MONTH:

Arash A. Alizadeh, MD, PhD, instructor, medicine-oncology, received a three-year, $200,000 Career Development Award from the American Society of Clinical Oncology. The award is presented to physicians who are within their first to third year of a full-time, primary faculty appointment in a clinical department at an independent clinical cancer research program.

Steven Artandi, MD, PhD, associate professor of medicine-hematology, was awarded a $1.43 million grant from the California Institute for Regenerative Medicine. The grant will fund a study of how induced pluripotent stem cells, also called iPS cells, choose between self-renewing or entering a resting state called senescence. He plans to study iPS cells created from the skin of people with mutations in an enzyme called telomerase, which is important in self-renewal. Understanding how to prevent senescence is a vital step toward using these cells as therapies.

On May 6, Scarlett Lin Gomez, PhD, a population scientist at our research partner, the Cancer Prevention Institute of California, addressed an audience of over 900 people at the Asian and Pacific Islander American Health Forum at the National Press Club in Washington, D.C. Gomez, a member of the Stanford Cancer Center, is an expert in cancer care and outcomes disparities. Her presentation focused on disparities in breast cancer survival in Asian American and Pacific Islander women.

Roel Nusse, PhD, professor and chair, department of development biology and member of the Howard Hughes Medical Institute, has been elected a member of the National Academy of Sciences.

Stephen T. Oh, MD, PhD, postdoctoral medical fellow, medicine, won an American Association for Cancer Research GlaxoSmithKline Outstanding Clinical Scholar Award, for his study, “Mutation of the inhibitory adaptor protein LNK drives potentiated JAK-STAT signaling in patients with JAK2 V617F-negative myeloproliferative neoplasms.” The award supports promising young cancer researchers who are the authors of outstanding proffered papers related to clinical research. Garry Nolan, PhD, professor of microbiology & immunology, and Jason Gotlib, MD, assistant professor of medicine-hematology, were co-senior authors on the paper.

Russell K. Pachynski, MD,instructor, medicine-oncology and postdoctoral research fellow, pathology, was presented with a Minority Scholar in Cancer Research Award from the American Association for Cancer Research. The award is intended to enhance the education and increase recognition of minorities involved in cancer research.

Joseph B. Shrager, MD, professor of cardiothoracic surgery and chief, division of thoracic surgery, was recently elected to the American Surgery Association, the oldest and most prestigious surgical society.

Finally, we congratulate the individuals whose research will be highlighted during the American Society of Clinical Oncology annual meeting in Chicago on June 4 through June 8: Ranjana Advani, MD; Hongbin Cao, MS; Karen P. M. Chu, MD; Christelle Clement-Duchene; A. Dimitrios Colevas, MD; Alice C. Fan, MD; Kristen N. Ganjoo, MD; Matthew A. Gubens, MD, MS; Lauren C. Harshman, MD; Holbrook Kohrt, MD; Pamela L. Kunz, MD; and Heather Wakelee, MD.

Sincerely,

Bev

Beverly Mitchell Signature
Beverly S. Mitchell, MD
Director, Stanford Cancer Center

(April 2010 Director's Message)

(Posted 05/12/10)

Stanford Medicine Resources:

Footer Links: